2022 annual financial data
Cellectar Biosciences 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -28,813,773 USD and net income was -28,601,254 USD.
Operating cash flow was -25,222,301 USD.
Get free Cellectar Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -28,813,773 USD
- Net income
- -28,601,254 USD
- Operating cash flow
- -25,222,301 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cellectar Biosciences financial years